Loading organizations...
Nausicaa Ventures operates as an early-stage investment fund, specializing in financing rounds from one to four million euros for developing companies. The firm employs a hybrid model, integrating capital from institutional venture groups and private investors. This structure allows Nausicaa Ventures to deploy substantial resources, specialized knowledge, and agile expertise to its portfolio.
Established in 2009, Nausicaa Ventures originated from the collective initiative of private individuals and institutional backers, including the European Investment Fund and ING Bank. An experienced investment team formed this consortium, identifying a significant "equity gap" hindering promising early-stage businesses. The firm was founded to bridge this critical financial need.
The fund primarily supports nascent companies poised for rapid growth, especially during initial scaling phases. Nausicaa Ventures actively collaborates with its portfolio, offering hands-on support and strategic guidance. Its vision centers on fostering profitable expansion and facilitating successful strategic exits for its ventures.
Nausicaa Ventures has 4 tracked investments across 2 companies. The latest tracked deal is $19.0M Series C in NGDATA in December 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 5, 2017 | NGDATA | $19.0M Series C | Manfred Krikke | Capricorn Venture Partners, Idinvest Partners, Pamica, Smartfin |
| Jan 5, 2017 | NGDATA | $9.4M Series B Extension | Idinvest Partners | Capricorn Venture Partners, Pamica, Smartfin |
| Oct 28, 2015 | NGDATA | $10.2M Series B | LUC Maruenda | Capricorn Venture Partners, Michel Akkermans, Smartfin |
| Jan 28, 2013 | Bone Therapeutics | $10.4M Grant / Series D | — | Bams Angel Fund, Life Sciences Research Partners, Sambrinvest, Sriw |